diatrizoate sodium (Hypaque)

Introduction

Tradename: Hypaque.

Indications

• cerebral angiography
• urography
  • cystourethrography
• aortography
• arteriography
• splenoportography
• examination of the GI tract (powder)
• computerized tomography
• intravenous pyelography
• cholangiography
• hysterosalphingography
• venography

Contraindications

Pregnancy category: C

Dosage

Injection: 25% (300 mL), 50% (20 mL, 30 mL, 50 mL)

Adverse effects

• anaphylactoid reaction 1-10%
• (see diatrizoate)

• drug adverse effects of contrast agents

More general terms

• diatrizoate
• pharmacologic combination

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=12916
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5284541